Long-Term Outcomes of a Multicenter Aspirin Deprescribing Intervention

This quality improvement study examines whether an aspirin deprescription intervention is associated with a sustained decrease in aspirin use among patients receiving warfarin for venous thromboembolism and/or atrial fibrillation.

Corresponding Author: Jordan K. Schaefer, MD, MSc, Department of Internal Medicine, Division of Hematology/Oncology, 1500 E Medical Center Dr, C366, Ann Arbor, MI 48109 (jschaef@med.umich.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.